Novel Therapy for Poor Responders Management
NCT04310293
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Poor Ovarian Response
Interventions
OTHER:
Femara,Grotwth hormone,HMG
Sponsor
Al Baraka Fertility Hospital